TpAML seeks to build collaboration, coordination, and communication across funders of pediatric AML research. The vision is NOT to create additional competition for foundations with TpAML. We encourage and invite every foundation that supports pediatric cancer and/or blood cancer research to participate in TpAML in ways that align with their operating model. From July 2016 through August 2017, our partners have raised and pooled over $2.45 million to speed personalized, precision medicine for young AML patients – THANK YOU. We are one team with different jerseys, working TOGETHER.